Alembic Pharmaceuticals share price rose in the opening trade on June 8 after the company signed a shareholders' agreement to invest in a newly incorporated Canadian entity, Canada Inc., aimed at ...

AI Quick Read Alembic Pharmaceuticals Ltd is expanding its branded speciality drugs portfolio in the US as part of a ‘twin engine play’ to boost growth in the market as generic pricing pressure ...

Alembic Pharmaceuticals has secured approval from the US health regulator for a generic seizure medication. The company received final clearance from the USFDA for Lamotrigine orally disintegrating ...

Alembic Pharmaceuticals Ltd on Wednesday said it has received final approval from the US Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Difluprednate ...

Alembic Pharmaceuticals Ltd on Monday said it has received tentative approval from the US health regulator for its Bosutinib tablets used in the treatment of certain types of cancer. The tentative ...

Drugmaker Alembic Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Travoprost Ophthalmic Solution ...

Alembic Pharmaceuticals Share Price | The tablets are indicated for the management of chronic stable angina and angina due to coronary artery spasm. Alembic Pharmaceuticals share price rose 2 percent ...

Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...

Alembic Technologies has raised $145 million in Series B and growth funding at a valuation 15 times higher than its previous round, betting that the next competitive advantage in artificial ...

Alembic Pharmaceuticals Limited has announced that it has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ticagrelor Tablets, 60 mg.